Search Results - David Peng
- Showing 1 - 4 results of 4
-
1
-
2
-
3
774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma by Kevin Kelly, Gino K In, Jeffrey Sosman, Sunandana Chandra, Jacob Thomas, Fumito Ito, Daniel Kwon, Hugo Lara Martinez, Erin Barrett, Ashley Wysong, Alissa Marr, Joshua Mammen, Thomas Won, Anisa Sandin, Sophia Marmolejo, Andrew Zeng, Niels Kokot, Mark Swanson, Denice Tsao-Wei, Susan Groshen, Andy Sherrod, Brittney Declerck, Gene Kim, David Peng, Jenny C Hu
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
4
Double bridge to heart transplantation: Outcomes of early versus delayed extracorporeal membrane oxygenation crossover in pediatric populationCentral MessagePerspective by Kishore R. Raja, MD, Shezad Muhammad Farrukh, MD, Benjamin Kroslowitz, MS, Matthew J. O'Connor, MD, Lawrence Greiten, MD, Jennifer Conway, MD, Chesney Castleberry, MD, Aamir Jeewa, MD, Christina VanderPluym, MD, Mark Bleiweis, MD, John J. Parent, MD, David Peng, MD, Aryaz Sheybani, MD, Gonzalo Wallis, MD, Deepa Mokshagundam, MD, David W. Bearl, MD, Lindsay May, MD, Arene Butto, MD, Natalie Shwaish, MD, Shahnawaz Amdani, MD, Robroy MacIver, MD, Ashish Ankola, MD, Jennifer A. Su, MD, Bethany Wisotzkey, MD, Neha Bansal, MD, Sabrina Law, MD, Svetlana B. Shugh, MD, Sarah Wilkens, MD, Katerina Boucek, MD, Scott Auerbach, MD, Pranava Sinha, MD, MBA
Published in JTCVS Open (2026-04-01)Get full text
Article
